In Brief This Week: Bruker; QuantRx; Avesthagen; Cold Spring Harbor Laboratory; BlackBio | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker Energy & Supercon Technologies, a subsidiary of bruker, has filed for an initial public offering in the US. The firm did not say in the prospectus how many shares it intends to offer, and it listed $100 million as the estimated maximum aggregate offering price. Following the offering, parent firm Bruker will continue to hold the majority of shares in BEST, which sells superconducting materials used in applications, such as MRI, NMR, and fusion energy research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.